WHO (2020) World Health Organization, news, WHO reveals leading causes of death and disability worldwide: 2000–2019. WHO, Geneva

Google Scholar 

Roth GA, Mensah GA, Johnson CO et al (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol 76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010

Article  PubMed  PubMed Central  Google Scholar 

Mancini GBJ, Hartigan PM, Shaw LJ et al (2014) Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. JACC Cardiovasc Interv 7(2):195–201. https://doi.org/10.1016/j.jcin.2013.10.017

Article  PubMed  Google Scholar 

Ahmadi A, Stone GW, Leipsic J et al (2016) Prognostic Determinants of Coronary Atherosclerosis in Stable Ischemic Heart Disease: Anatomy, Physiology, or Morphology? Circ Res 119:317–329. https://doi.org/10.1161/CIRCRESAHA.116.308952

Article  CAS  PubMed  Google Scholar 

Nichols M, Townsend N, Scarborough P, Rayner M (2014) Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 35(42):2929–2933. https://doi.org/10.1093/eurheartj/ehu378

Article  PubMed  Google Scholar 

Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612

Article  PubMed  Google Scholar 

Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272. https://doi.org/10.1378/chest.09-1584

Article  PubMed  Google Scholar 

Chan YH, Yiu KH, Lau KK et al (2014) The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: Role of incorporating PR prolongation. Atherosclerosis 237(2):504–513. https://doi.org/10.1016/j.atherosclerosis.2014.08.026

Article  CAS  PubMed  Google Scholar 

Chua SK, Lo HM, Chiu CZ, Shyu KG (2014) Use of CHADS2 and CHA2DS2-VASc Scores to Predict Subsequent Myocardial Infarction, Stroke, and Death in Patients with Acute Coronary Syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry. PLoS ONE 9(10):e111167. https://doi.org/10.1371/journal.pone.0111167

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang X, Lv H, Liu Z, Liu Y, Yang X (2022) Study on the predictive ability of emergency CHADS2 score and CHA2DS2-VASc score for coronary artery disease and prognosis in patients with acute ST-segment elevation myocardial infarction. J Thorac Dis 14(7):2611–2620. https://doi.org/10.21037/jtd-22-763

Article  PubMed  PubMed Central  Google Scholar 

Barman HA, Kahyaoglu S, Durmaz E et al (2020) The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction. Coron Artery Dis 31(1):7–12. https://doi.org/10.1097/MCA.0000000000000781

Article  PubMed  Google Scholar 

Sun Y, Ren J, Wang W, Wang C, Li L, Yao H (2023) Predictive value of CHA2DS2-VASc score for in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary PCI. Clin Cardiol 46(8):950–957. https://doi.org/10.1002/clc.24071

Article  PubMed  PubMed Central  Google Scholar 

Temizer O, Açar B, Yayla, et al (2017) The association between CHA2DS2-VASc score and mortality in patients with heart failure with reduced ejection fraction. Acta Cardiol Sin 33(4):429–435. https://doi.org/10.6515/ACS20170221A

Article  PubMed  PubMed Central  Google Scholar 

Chen YL, Cheng CL, Huang JL et al (2017) Mortality prediction using CHADS2 /CHA2 DS2-VASc/R2 CHADS2 scores in systolic heart failure patients with or without atrial fibrillation. Medicine. https://doi.org/10.1097/MD.0000000000008338

Article  PubMed  PubMed Central  Google Scholar 

Sonaglioni A, Lonati C, Rigamonti E et al (2022) CHA2DS2-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation. Aging Clin Exp Res 34(7):1707–1720. https://doi.org/10.1007/s40520-022-02107-x

Article  PubMed  PubMed Central  Google Scholar 

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR et al (2013) Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention. The Lancet 382(9889):339–352. https://doi.org/10.1016/S0140-6736(13)60595-4

Article  Google Scholar 

Thompson S, James M, Wiebe N et al (2015) Cause of Death in Patients with Reduced Kidney Function. J Am Soc Nephrol 26(10):2504–2511. https://doi.org/10.1681/ASN.2014070714

Article  PubMed  PubMed Central  Google Scholar 

Piscitelli P, D’Errico MM, Mirijello A et al (2022) Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality. Nutr Metab Cardiovasc Dis 32(2):402–409. https://doi.org/10.1016/j.numecd.2021.09.036

Article  CAS  PubMed  Google Scholar 

Kiliszek M, Szpakowicz A, Filipiak KJ et al (2015) CHA2DS2-VASc and R2CHA2DS2-VASc scores have predictive value in patients with acute coronary syndromes. Pol Arch Intern Med 125(7–8):545–552. https://doi.org/10.20452/pamw.2965

Article  Google Scholar 

D’Errico MM, Piscitelli P, Mirijello A et al (2022) CHA2DS2-VASc and R2CHA2DS2-VASc scores predict mortality in high cardiovascular risk population. Eur J Clin Invest. https://doi.org/10.1111/eci.13830

Article  PubMed  Google Scholar 

Fu S, S, Zhou S, Luo L, Ye P, (2017) R2(GFR) CHADS2 and R2(GFR) CHA2DS2VASc schemes improved the performance of CHADS2 and CHA2DS2VASc scores in death risk stratification of Chinese older patients with atrial fibrillation. Clin Interv Aging 12:1233–1238. https://doi.org/10.2147/CIA.S138405

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parsons C, Cha S, Shen WK et al (2018) Usefulness of the Addition of Renal Function to the CHA2DS2-VASc Score as a Predictor of Thromboembolism and Mortality in Patients Without Atrial Fibrillation. Am J Cardiol 122(4):597–603. https://doi.org/10.1016/j.amjcard.2018.04.049

Article  PubMed  PubMed Central  Google Scholar 

Barra S, Almeida I, Caetano F et al (2013) Stroke prediction with an adjusted R-CHA2DS2VASc score in a cohort of patients with a Myocardial Infarction. Thromb Res 132(2):293–299. https://doi.org/10.1016/j.thromres.2013.06.025

Article  CAS  PubMed  Google Scholar 

Cetin M, Cakici M, Zencir C et al (2014) Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA 2DS2-VASc-HS score. Am J Cardiol 113(6):950–956. https://doi.org/10.1016/j.amjcard.2013.11.056

Article  PubMed  Google Scholar 

Scudiero F, Zocchi C, De Vito E et al (2018) Relationship between CHA2DS2-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndrome. Int J Cardiol 262:9–13. https://doi.org/10.1016/j.ijcard.2018.03.086

Article  PubMed  Google Scholar 

Visseren FLJ, Mach F, Smulders YM et al (2021) 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J 42(34):3227–3337. https://doi.org/10.1093/eurheartj/ehab484

Article  PubMed  Google Scholar 

D’Errico MM, Mangiacotti A, Graziano D et al (2017) Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes. Acta Diabetol 54(11):1065–1068. https://doi.org/10.1007/s00592-017-1022-x

Article  PubMed  Google Scholar 

Piscitelli P, Mangiacotti A, Marchese N et al (2020) Reduced glomerular filtration rate and prior cardiovascular event entail similar risk for coronary atherosclerotic burden. Eur Rev Med Pharmacol Sci 24:9063–9070. https://doi.org/10.26355/eurrev_202009_22852

Article  CAS  PubMed  Google Scholar 

Serruys PW, Unger F, van Hout BA et al (1999) The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol 4:209–219. https://doi.org/10.1006/siic.1999.0107